We are live on
!
Find out more
ACM
Accipiter Capital Management Portfolio holdings
AUM
$124M
1-Year Est. Return
6.47%
This Fund
S&P 500
This Quarter
Est. Return
+17.7%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow
% of AUM
93.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
8
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTS
Triple-S Management Corporation
GTS
|
+$43.2M |
| 2 |
Elevance Health
ELV
|
+$16M |
| 3 |
AET
Aetna Inc
AET
|
+$15.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$14.1M |
| 5 |
Cigna
CI
|
+$11.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.6% |
| 2 | Healthcare | 43.59% |
| 3 | Technology | 6.81% |
Similar funds
ACM
MCM
TCM
ALIONA
HA
DFIG
PAM
KC
Accipiter Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Accipiter Capital Management, which disclosed 8 positions worth $127M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Triple-S Management Corporation: 2,292,943 shares worth $46.8M.
By sector, the portfolio is most concentrated in Financials at 50% of assets, followed by Healthcare and Technology.
- Accipiter Capital Management's largest Q2 2013 buy was Triple-S Management Corporation: 2,292,943 shares worth $46.8M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $127M portfolio in Q2 2013.
- Accipiter Capital Management disclosed 8 positions in Q2 2013, its first 13F filing on record.
Based on Accipiter Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.